Epithelial-to-mesenchymal transition in neutrophilic chronic rhinosinusitis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ryu, Gwanghui | - |
dc.contributor.author | Mo, Ji-Hun | - |
dc.contributor.author | Shin, Hyun-Woo | - |
dc.date.accessioned | 2021-08-11T08:30:09Z | - |
dc.date.available | 2021-08-11T08:30:09Z | - |
dc.date.issued | 2021-02 | - |
dc.identifier.issn | 1528-4050 | - |
dc.identifier.issn | 1473-6322 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2069 | - |
dc.description.abstract | Purpose of review Barrier dysfunction, tissue fibrosis, and remodeling are essential processes of the pathophysiology of chronic rhinosinusitis (CRS). The role of epithelial-to-mesenchymal transition (EMT) has been assessed in various studies in CRS. In this review, we summarized the pathophysiologic mechanisms of EMT related to CRS, particularly neutrophilic CRS. Recent findings Loss of epithelial characteristics due to EMT makes leaky epithelium, and transformed mesenchymal cells cause fibrosis and remodeling. Hypoxia, allergens (house dust mites), infections, and air pollutants were related to the pathogenesis of neutrophilic CRS, and these factors are known to induce barrier dysfunction and EMT in sinonasal epithelia. Some molecular pathways related to EMT have been recognized in CRS, including interferon-gamma/p38/extracellular signal-regulated kinase, high-mobility group box 1/receptor of advanced glycosylation end-products, TGF-beta 1/SMAD, and Wnt/beta-catenin-signaling pathways. Apart from, several microRNAs (miR-21, miR-761, and miR-30a-5p) have been identified to regulate EMT in CRS. Summary EMT is considered to be an important pathogenesis mechanism for CRS. The factors cause EMT in CRS, and the associated molecular mechanisms are related to neutrophilic inflammation. Further studies on CRS endotype and/or phenotype are needed to clarify the implication of EMT on CRS pathogenesis. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
dc.title | Epithelial-to-mesenchymal transition in neutrophilic chronic rhinosinusitis | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1097/ACI.0000000000000701 | - |
dc.identifier.scopusid | 2-s2.0-85099113517 | - |
dc.identifier.wosid | 000605739900006 | - |
dc.identifier.bibliographicCitation | Current Opinion in Allergy and Clinical Immunology, v.21, no.1, pp 30 - 37 | - |
dc.citation.title | Current Opinion in Allergy and Clinical Immunology | - |
dc.citation.volume | 21 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 30 | - |
dc.citation.endPage | 37 | - |
dc.type.docType | Review | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Allergy | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalWebOfScienceCategory | Allergy | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.subject.keywordPlus | GLYCATION END-PRODUCTS | - |
dc.subject.keywordPlus | NASAL POLYPS | - |
dc.subject.keywordPlus | AIRWAY EPITHELIUM | - |
dc.subject.keywordPlus | BARRIER FUNCTION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | HYPOXIA | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | POLYPOGENESIS | - |
dc.subject.keywordPlus | PATHOGENESIS | - |
dc.subject.keywordPlus | INTEGRITY | - |
dc.subject.keywordAuthor | epithelial-to-mesenchymal transition | - |
dc.subject.keywordAuthor | interferon-gamma | - |
dc.subject.keywordAuthor | nasal polyp | - |
dc.subject.keywordAuthor | neutrophil | - |
dc.subject.keywordAuthor | rhinosinusitis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.